Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Price

Showing results (771-780 of 1,128) with videos related to

Pageof 113
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95, Russell L Basser, Anne O'Neill, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 24, 2025
Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network TrialsSarah N Price, Stephanie R Land, Kinsey Pebley, et al.
The Journal of Infectious Diseases|July 27, 2016
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in ThailandSarah Auburn, David Serre, Richard D Pearson, et al.
International Journal of Women'S Dermatology|July 5, 2021
Provider perspectives on the management of hidradenitis suppurativa in pregnancy - A survey studyErin K Collier, Kyla N Price, Tristan Grogan, et al.
Plos One|June 12, 2008
Safety profile of L-arginine infusion in moderately severe falciparum malariaTsin W Yeo, Daniel A Lampah, Retno Gitawati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Pathogens (Basel, Switzerland)|January 5, 2021
Diagnostic Practices and Treatment for <i>P. vivax</i> in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods StudyThuan Thi Nguyen, Xa Xuan Nguyen, Maya Ronse, et al.
The Journal of Infectious Diseases|September 22, 2018
Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent MalariaJessica R Loughland, Tonia Woodberry, Michelle J Boyle, et al.
Malaria Journal|December 12, 2018
Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillanceMatthew J Grigg, Timothy William, Kim A Piera, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal PhenotypesGrennady Wirjanata, Irene Handayuni, Pak Prayoga, et al.
Pageof 113

Showing results (771-780 of 1,128) with videos related to

Sort By:
Pageof 113
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95, Russell L Basser, Anne O'Neill, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 24, 2025
Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network TrialsSarah N Price, Stephanie R Land, Kinsey Pebley, et al.
The Journal of Infectious Diseases|July 27, 2016
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in ThailandSarah Auburn, David Serre, Richard D Pearson, et al.
International Journal of Women'S Dermatology|July 5, 2021
Provider perspectives on the management of hidradenitis suppurativa in pregnancy - A survey studyErin K Collier, Kyla N Price, Tristan Grogan, et al.
Plos One|June 12, 2008
Safety profile of L-arginine infusion in moderately severe falciparum malariaTsin W Yeo, Daniel A Lampah, Retno Gitawati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Pathogens (Basel, Switzerland)|January 5, 2021
Diagnostic Practices and Treatment for <i>P. vivax</i> in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods StudyThuan Thi Nguyen, Xa Xuan Nguyen, Maya Ronse, et al.
The Journal of Infectious Diseases|September 22, 2018
Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent MalariaJessica R Loughland, Tonia Woodberry, Michelle J Boyle, et al.
Malaria Journal|December 12, 2018
Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillanceMatthew J Grigg, Timothy William, Kim A Piera, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal PhenotypesGrennady Wirjanata, Irene Handayuni, Pak Prayoga, et al.
Pageof 113